Brief: Aim Immunotech Announces Significant Increase In Stockholder Equity And Extension Of Promissory Note Maturity Date To June 2027
19/05/2026 14:50
May 19 (Reuters) - AIM ImmunoTech Inc AIM.A: AIM IMMUNOTECH ANNOUNCES SIGNIFICANT INCREASE IN STOCKHOLDER EQUITY AND EXTENSION OF PROMISSORY NOTE MATURITY DATE TO JUNE 2027, ENHANCING FINANCIAL FLEXIBILITY AND SUPPORTING STRATEGIC CLINICAL PRIORITIES AIM IMMUNOTECH INC - EXTENDS PROMISSORY NOTE MATURITY TO JUNE 30, 2027; OUTSTANDING BALANCE $1.68 MILLION Source text: ID:nGNX24BsNm Further company coverage: AIM.A ((Reuters.Briefs@thomsonreuters.com;))
Recent news on AIM ImmunoTech
See all newsBrief: Aim Immunotech Duripanc Primary Endpoint Analysis To Begin December 2026 Topline Results Expected Q1 2027
Brief: Aim Immunotech Files To Offer And Resell Up To 13.08 Million Shares Of Common Stock By Selling Stockholders
Brief: AIM ImmunoTech Announces $2.65 Million Financing Priced At-Market Under NYSE American Rules
Brief: Aim Immunotech Announces Significant Increase In Stockholder Equity And Extension Of Promissory Note Maturity Date To June 2027
Brief: Aim Immunotech Announces 50% Objective Response Rate (Orr) In Upmc Recurrent Ovarian Cancer Phase 2 Clinical Trial, Suggesting Breakthrough Combination Potential